StreetAlpha
13F holdings · Q3 2026

Nvp Associates

Menlo Park, CA · files as Nvp Associates, LLC
Know the moment Nvp Associates filesYou follow Nvp Associates An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 13, 2026Next filing due Feb 15, 2027CIK 1545692

Nvp Associates reported 6 stocks worth $282M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are MBX (44.4%), AVLN (22.9%) and ZBIO (17.6%). Compared with Q2 2026, the fund sold out of OMDA.

Latest filing: what Nvp Associates did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
0 new0 added0 trimmed1 sold outBought about $0 · sold about $55.6M
New 0

None

Added 0

None

Trimmed 0

None

Sold out 1

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$282M−14.1% vs last quarter
Stocks held60 new · 1 sold out
Top 5 weight100.0%very concentrated
Turnover20%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
MBX
Mbx Biosciences Inc
$125M44.4%2.1MNo change8 of 8
2
AVLN
Avalyn Pharma Inc
$64.6M22.9%2.3MNo change2 of 8
3
ZBIO
Zenas Biopharma Inc
$49.6M17.6%1.8MNo change8 of 8
4
SNOW
Snowflake Inc
$39M13.8%115KNo change2 of 8
5
GROV
Grove Collaborative Hold Inc
$3.4M1.2%3.2MNo change8 of 8
6
ONDS
Ondas Hldgs Inc
$114K0.0%16KNo change2 of 8

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
OMDA
Omada Health Inc
$55.6M2.5M

Reported value

last 8 quarters
$187MQ4 '24
$112MQ1 '25
$184MQ2 '25
$166MQ3 '25
$255MQ4 '25
$176MQ1 '26
$328MQ2 '26
$282MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 13, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Nvp Associates 13F FAQ

What does Nvp Associates own?

Nvp Associates reported 6 stocks worth $282M in its 13F filing for Q3 2026, filed Nov 13, 2026. Its largest holdings are MBX (44.4%), AVLN (22.9%) and ZBIO (17.6%). The table above lists every position in the filing (the top 10 without an account).

What did Nvp Associates buy and sell in Q3 2026?

Compared with Q2 2026: 0 new positions, 0 added to, 0 trimmed and 1 sold out. It sold all of OMDA.

When will Nvp Associates file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Nvp Associates's portfolio worth?

The Q3 2026 filing reports $282M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.